ACM
NAVB
Allred Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-466,688
| Closed | -$41.9K | – | 169 |
|
|
2023
Q3 | $41.9K | Buy |
466,688
+172,850
| +59% | +$15.5K | 0.02% | 151 |
|
|
2023
Q2 | $27K | Buy |
293,838
+129,100
| +78% | +$11.9K | 0.01% | 159 |
|
|
2023
Q1 | $42.8K | Buy |
164,738
+54,300
| +49% | +$14.1K | 0.02% | 156 |
|
|
2022
Q4 | $23.2K | Buy |
110,438
+63,200
| +134% | +$13.3K | 0.01% | 152 |
|
|
2022
Q3 | $11K | Buy |
47,238
+10,400
| +28% | +$2.42K | 0.01% | 150 |
|
|
2022
Q2 | $26K | Sell |
36,838
-14,784
| -29% | -$10.4K | 0.02% | 155 |
|
|
2022
Q1 | $40K | Sell |
51,622
-1,616
| -3% | -$1.25K | 0.02% | 168 |
|
|
2021
Q4 | $53K | Sell |
53,238
-11,750
| -18% | -$11.7K | 0.03% | 184 |
|
|
2021
Q3 | $114K | Sell |
64,988
-8,800
| -12% | -$15.4K | 0.06% | 173 |
|
|
2021
Q2 | $135K | Buy |
73,788
+9,785
| +15% | +$17.9K | 0.07% | 179 |
|
|
2021
Q1 | $129K | Buy |
64,003
+11,077
| +21% | +$22.4K | 0.06% | 226 |
|
|
2020
Q4 | $113K | Sell |
52,926
-12,377
| -19% | -$26.4K | 0.06% | 168 |
|
|
2020
Q3 | $176K | Sell |
65,303
-3,163
| -5% | -$8.53K | 0.11% | 157 |
|
|
2020
Q2 | $269K | Buy |
68,466
+47,938
| +234% | +$188K | 0.17% | 124 |
|
|
2020
Q1 | $15K | Sell |
20,528
-3,600
| -15% | -$2.63K | 0.01% | 136 |
|
|
2019
Q4 | $30.4K | Buy |
24,128
+12,810
| +113% | +$16.1K | 0.02% | 404 |
|
|
2019
Q3 | $8K | Sell |
11,318
-8,100
| -42% | -$5.73K | ﹤0.01% | 163 |
|
|
2019
Q2 | $11K | Sell |
19,418
-233,257
| -92% | -$132K | 0.01% | 178 |
|
|
2019
Q1 | $35K | Buy |
252,675
+43,700
| +21% | +$6.05K | 0.02% | 188 |
|
|
2018
Q4 | $21K | Buy |
+208,975
| New | +$21K | 0.01% | 173 |
|